以质量求发展,以服务铸品牌

护理学报 ›› 2023, Vol. 30 ›› Issue (13): 42-46.doi: 10.16460/j.issn1008-9969.2023.13.042

• 循证护理 • 上一篇    下一篇

精准医学背景下母方案设计临床应用的范围综述

叶琴1, 周立霞2, 刘宁1   

  1. 1.遵义医科大学珠海校区 护理学系,广东 珠海 519041;
    2.遵义医科大学附属第五(珠海)医院 肿瘤科,广东 珠海 519041
  • 收稿日期:2023-04-03 出版日期:2023-07-10 发布日期:2023-08-04
  • 通讯作者: 刘宁(1981-),女,陕西西安人,博士,教授,博士研究生导师,南方医院JBI循证护理合作中心导师库成员。E-mail:761066906@qq.com
  • 作者简介:叶琴(1996-),女,贵州遵义人,本科学历,硕士研究生在读,护师。
  • 基金资助:
    国家自然科学基金(82260281)

Clinical application of master protocol design in precision medicine: a scoping review

YE Qin1, ZHOU Li-xia2, LIU Ning1   

  1. 1. Department of Nursing, Zhuhai Campus, Zunyi Medical University, Zhuhai 519041, China;
    2. Dept. of Oncology, the Fifth Affiliated Hospital, Zunyi Medical University, Zhuhai 519041,China
  • Received:2023-04-03 Online:2023-07-10 Published:2023-08-04

摘要: 目的 全面检索国内外母方案设计的相关研究,了解其临床应用所覆盖的研究领域,为国内护理人员开展母方案设计相关研究的实施和推广提供参考。方法 采用Arksey和O'Malley提出的范围综述方法,系统检索中国知网、万方数据库、中国生物医学文献数据库、维普、PubMed、Cochrane Library、Embase、Web of Science,检索时限为从建库至2023年4月。根据纳入、排除标准筛选文献,2名研究者独立提取母方案设计核心要素及其应用领域相关资料,采用描述性分析及主题分析法对提取结果进行整理。结果 共纳入104篇文献,研究领域涉及肿瘤、临床心理学、新型冠状病毒肺炎等的药物开发评估及个性化健康计划的制定。母方案在国内外应用存在着明显差异,主要体现在3个方面:(1)应用范围不同,国外主要用于评估新药、疗法或医学器材的有效性和安全性,而在我国广泛应用于中医药领域;(2)研究类型有别,国外主要应用多中心随机对照试验、队列研究,而我国此类型研究相对较少;(3)经验和技术支持方面,由于历史和文化背景等原因,国外研究者在母方案的设计和实施方面拥有更丰富的经验和技术支持。因此,在推广和应用母方案时,需充分考虑国内外的差异,并结合本土实际情况探索出适合自身条件下的研究模式和方法,以推进其更广泛和深入的应用。结论 母方案的实施是临床研究模式的一次突破性创新,当前母方案设计的应用多集中在肿瘤学、新型冠状病毒肺炎领域,但伞式试验和篮式试验可用于健康领域,平台试验的范围可应用于临床心理学和数字心理健康干预,国内护理研究者应重视对母方案设计的应用,在其指导下开展相关研究,提升护士创新行为,积极寻找新方法和技术,循证优化试验设计,解决临床护理问题,快速适应精准医学的发展。

关键词: 母方案, 篮式试验, 伞式试验, 平台试验, 精准医学, 范围综述

Abstract: Objective To conduct a comprehensive search on studies regarding master protocols design at home and abroad, to understand the research fields in clinical application, and to provide reference for the implementation and promotion of the research about master protocol design by domestic nursing staff. Methods The scoping review proposed by Arksey and O'Malley was used, and we systematically searched literature in databases of CNKI, Wanfang Database, China Biomedical Literature Database, VIP Database, PubMed, Cochrane Library, Embase,and Web of science from the inception to April 2023. According to the inclusion and exclusion criteria, two researchers independently extracted the core elements of master protocol design and its application, and descriptive analysis and thematic analysis were used to sort out the data. Results A total of 104 pieces of literature were collected, covering oncology, psychology, traditional Chinese medicine, neurology, COVID-19 and drug development evaluation. There were significant differences in the application of master protocols between China and foreign countries, which can be mainly reflected in three aspects. 1) Different application scopes. In foreign countries master protocols were mainly used to evaluate the effectiveness and safety of new drugs, therapies or medical equipment, while in China it was widely applied to traditional Chinese medicine. 2) Different types of research. Multi-center randomized controlled trials and cohort studies were commonly used in foreign countries, while there was relatively less such research in China; 3) Differences in experience and technical support. Richer experience and technical support in the design and implementation of master protocols due to historical and cultural background were observed in foreign countries. Therefore, when promoting and applying master protocols, it was necessary to fully consider the differences between China and foreign countries, and explore suitable research models and methods that fit the local conditions, so as to promote the wider and deeper application. Conclusion The implementation of the master protocols is a breakthrough innovation of the clinical research. At present, the application of master protocols is mainly concentrated in the field of oncology and COVID-19, but the umbrella trial and basket trial can be used in the health field, and the platform trial can be applied to clinical psychology and digital mental health intervention. Domestic nursing researchers should pay attention to the application of master protocols and carry out researches under its guidance to optimize the trial design to adapt to the development of precision medicine.

Key words: master protocol, basket trial, umbrella trial, platform trial, precision medicine, scoping review

中图分类号: 

  • R197.323.6
[1] Subbiah V.The next generation of evidence-based medicine[J]. Nat Med, 2023,29(1):49-58. DOI:10.1038/s41591-022-02160-z.
[2] Redman MW, Allegra CJ.The master protocol concept[J]. Semin Oncol,2015,42(5):724-730.DOI:10.1053/j.seminoncol.2015.07.009.
[3] Di Liello R, Piccirillo MC, Arenare L, et al.Master protocols for precision medicine in oncology: overcoming methodology of randomized clinical trials[J]. Life (Basel), 2021,11(11):1253. DOI: 10.3390/life11111253.
[4] Woodcock J, LaVange LM.Master protocols to study multiple therapies, multiple diseases,or both[J]. N Engl J Med, 2017,377(1):62-70. DOI:10.1056/NEJMra1510062.
[5] 于亚南,杜培艳,刘骏,等. 精准医学创新性临床试验设计“主方案”研究的概念、设计与案例[J]. 中国新药杂志,2020, 29(23):2712-2717.DOI:10.3969/j.issn.1003-3734.2020.23.014.
[6] Arksey H, O'Malley L. Scoping studies: towards a methodological framework[J]. Int J Soc Res Method, 2005, 8(1): 19-32. DOI:10.1080/1364557032000119616.
[7] Aromataris E, Riitano D.Constructing a search strategy and searching for evidence. A guide to the literature search for a systematic review[J]. Am J Nurs, 2014,114(5):49-56. DOI: 10.1097/01.NAJ.0000446779.99522.f6.
[8] Liu W, Zhou L, Feng L, et al.BuqiTongluo granule for ischemic stroke, stable angina pectoris, diabetic peripheral neuropathy with Qi deficiency and blood stasis syndrome: rationale and novel basket design[J]. Front Pharmacol, 2021(12):764669. DOI: 10.3389/fphar.2021.764669.
[9] Lamb JJ, Stone M, D'Adamo CR, et al. Personalized lifestyle intervention and functional evaluation health outcomes survey: presentation of the LIFEHOUSE study using N-of-one tent-umbrella-bucket design[J]. J Pers Med, 2022,12(1):115. DOI: 10.3390/jpm12010115.
[10] Millen GC, Yap C.Adaptive trial designs: what are multiarm, multistage trials?[J]. Arch Dis Child Educ Pract Ed, 2020,105(6):376-378.DOI:10.1136/archdischild-2019-317826.
[11] 关之玥,刘岩,张晶晶,等. 母方案平台试验设计方法及其在相关领域中的应用[J]. 中国循证医学杂志,2021,21(8):986-992. DOI:10.7507/1672-2531.202104005.
[12] Gold, S, Bofill Roig, M, Miranda, J, et al. Platform trials and the future of evaluating therapeutic behavioural interventions[J]. Nat Rev Psychol, 2022,1(1):7-8. DOI:10.1038/s44159-021-00012-0.
[13] Werner-Seidler A, Hitchcock C, Bevan A, et al.A cluster randomized controlled platform trial comparing group memory specificity training (MEST) to group psychoeducation and supportive counselling (PSC) in the treatment of recurrent depression[J]. Behav Res Ther, 2018(105):1-9. DOI: 10.1016/j.brat.2018.03.004.
[14] Wells A, Fisher P, Myers S, et al.Metacognitive therapy in treatment-resistant depression: a platform trial[J]. Behav Res Ther,2012,50(6):367-373. DOI:10.1016/j.brat.2012.02.004.
[15] Dickson D, Johnson J, Bergan R, et al.The master observational trial: a new class of master protocol to advance precision medicine[J]. Cell, 2020,180(1):9-14. DOI:10.1016/j.cell.2019.12.009.
[16] Renfro LA, Sargent DJ.Statistical controversies in clinical research: basket trials, umbrella trials, and other master protocols: a review and examples[J]. Ann Oncol, 2017,28(1):34-43. DOI:10.1093/annonc/mdw413.
[17] Hyman DM, Solit DB, Arcila ME, et al.Precision medicine at Memorial Sloan Kettering Cancer Center: clinical next-generation sequencing enabling next-generation targeted therapy trials[J]. Drug Discov Today, 2015,20(12):1422-18. DOI:10.1016/j.drudis.2015.08.005.
[18] 赵晨,张晓雨,胡嘉元,等. 中医同证候系疾病临床研究母方案设计方法[J]. 中医杂志, 2018,59(2):111-115. DOI:10.13288/j.11-2166/r.2018.02.006.
[19] 陈莹, 常静玲, 代恒恒, 等. 精准医学模式下的母方案篮式试验设计方法及其在中医药领域中的应用[J]. 中国循证医学杂志, 2022, 22(4):483-489.
[20] 高珺,苏丽文,袁鹰,等. 抗肿瘤药物主方案试验设计进展及统计考量[J].中国卫生统计, 2021,38(6):950-955. DOI:10.3969/j.issn.1002-3674.2021.06.035.
[21] Angus DC, Berry S, Lewis RJ, et al.The REMAP-CAP (randomized embedded multifactorial adaptive platform for community-acquired pneumonia) study. rationale and design[J]. Ann Am Thorac Soc, 2020,17(7):879-891. DOI: 10.1513/AnnalsATS.202003-192SD.
[1] 邹自玉, 唐红梅, 吴丽, 陈荣凤, 梅花. 乳腺癌相关健康教育材料可读性评估的范围综述[J]. 护理学报, 2022, 29(9): 42-46.
[2] 朱展慧, 林征, 周美景, 王咪, 孙彩云, 顾珺怡. 决策辅助工具在炎症性肠病患者中应用的范围综述[J]. 护理学报, 2022, 29(7): 44-49.
[3] 张成果, 孙小玲, 卢山, 黄萍, 付逸超. 患者重症监护体验测量工具的范围综述[J]. 护理学报, 2022, 29(18): 53-58.
[4] 喻婷, 王聪, 刘珊珊, 杨智博, 寸薇, 蒋艳. 脑卒中患者安宁疗护需求的范围综述[J]. 护理学报, 2022, 29(14): 48-52.
[5] 牛雨田, 柏晓玲, 楼婷, 韦清, 李慧. 心理痛苦筛查工具的范围综述[J]. 护理学报, 2021, 28(20): 44-48.
[6] 王怡欣, 傅荣, 牛倩霞, 厉姝岑. 信息通信技术干预单纯性肥胖症成人患者的范围综述[J]. 护理学报, 2021, 28(14): 35-41.
[7] 王雪璐,胡嘉乐,Nicole Damico,阮洪. 围术期患者麻醉满意度问卷概述及应用进展[J]. 护理学报, 2017, 24(14): 26-30.
Viewed
Full text


Abstract

Cited

  Shared   
[1] 张侍玉, 王玉然, 赵姝姝, 王杰敏. 头颈癌放疗患者重度放射性口腔黏膜炎风险预测模型的构建与验证[J]. 护理学报, 2023, 30(10): 68 -72 .
[2] 张咪, 吴艳妮, 黄秀娥, 杨晶, 王润, 杨玲莉, 赵慧慧, 周春兰. 失能老人和配偶照顾者健康素养与自我效能对生活质量的交互作用[J]. 护理学报, 2023, 30(13): 1 -5 .
[3] 项晓婷, 张会, 苏畅, 胡桑, 张真, 许静, 仲蕾, 陆雅维. Caprini评分联合凝血指标构建PICC相关性血栓风险可视化模型[J]. 护理学报, 2023, 30(13): 6 -12 .
[4] 孙梦晨, 冯芳茗, 何佳倩, 范思雨, 杨颖, 季佳妮. 癌症患者自杀风险评估量表的编制及信效度检验[J]. 护理学报, 2023, 30(13): 13 -17 .
[5] 乔悦, 段培蓓, 王晓庆, 杨丽华, 邹炎铃, 费超男. 173例晚期癌症患者家庭回避癌症沟通现状及影响因素分析[J]. 护理学报, 2023, 30(13): 18 -23 .
[6] 黄宇星, 刘宁, 黄婷. 基于核心能力构建适宜中低资源地区护理本科循证实践教学指标体系[J]. 护理学报, 2023, 30(13): 24 -28 .
[7] 刘莉, 朋彩虹, 刘静. 双导师指导下的分学期递进式培养模式对护理专升本学生科研能力的影响[J]. 护理学报, 2023, 30(13): 29 -33 .
[8] 牛瑞, 宋晓东, 柴丹, 曹俊, 杨西宁. 医务人员卫生保健相关后悔的现状及应对策略研究[J]. 护理学报, 2023, 30(13): 34 -37 .
[9] 张颖, 刘雪琴, 刘晓辉, 聂亚杰, 章晓菲, 赵洁, 代楠, 王肖阳. 血液透析疲乏患者报告结局评估工具临床应用的研究进展[J]. 护理学报, 2023, 30(13): 38 -41 .
[10] 庄云婷, 王志坚, 李娟华, 肖燕璇, 刘益君. 妊娠期妇女不宁腿综合征管理的最佳证据总结[J]. 护理学报, 2023, 30(13): 47 -52 .